Aelis Farma SAS; Alcobra Ltd; AMO Pharma Limited; Confluence Pharmaceuticals LLC; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Marinus Pharmaceuticals Inc.; MI.TO. Technology S.r.L.; Neuren Pharmaceuticals Limited
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2019 | 94 | S&P Consulting | ASDR-482666 |
Aelis Farma SAS; Alcobra Ltd; AMO Pharma Limited; Confluence Pharmaceuticals LLC; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Marinus Pharmaceuticals Inc.; MI.TO. Technology S.r.L.; Neuren Pharmaceuticals Limited